Abstract:Abstract Background: Esophageal cancer (EC) is a malignant tumor with dreadful mortality, nomogram is a prognosis tool of great significance in therapeutic guidance and assessment. We aimed to establish a newly-built nomogram for OS prediction of EC patients with radical esophagectomy.Methods: A total of 311 EC patients underwent radical esophagectomy were retrospectively investigated with their survival and demographic and clinicopathological data. Patients were randomly divided into the primary and validation cohorts. The establishment of nomogram was based on Cox hazard regression analysis in primary cohort, the calibration curves and Harrell’s concordance index were performed to verify the predictive accuracy while ROC curves was adopted to reflect the efficacy of nomogram. Kaplan–Meier curves showed the clinical significance of risk classification system and Pearson correlation test was utilized to show the correlation between risk classification system and TNM staging.Results: The median OS and 5-year survival rate are 44 months and 29.8% in primary cohort. In validation cohort, they are 52 months and 27.1%, respectively. In Cox hazard regression analysis, we extracted six independent prognostic factors—age, gender, AGR, PRL, N stage, PNI—to establish the nomogram. The C-index of nomogram is 0.75 in primary cohort and 0.70 in validation cohort. Calibration curves indicated high consistency between accurate and predicted OS in both primary and validation cohorts. ROC curves showed a better efficacy of nomogram compared with AJCC T and N stage. The area under curve (AUC) of primary cohort is 0.801 and 0.727 in validation cohort. Patients in primary cohort were divided into three risk groups according to the nomogram score, the median OS between each group was significantly different. Analogical results were obtained in validation cohort. Furthermore, the risk classification system was strongly correlated to AJCC TNM staging system in total cohort (r2=0.647, P<0.001), and it also demonstrated a better OS prediction efficacy (AUC=0.742).Conclusions: We established a neotype nomogram and a relevant risk classification system with verified accuracy and efficacy in OS prediction of EC patients after radical esophagectomy. They may provide feasible value in prognosis assessment and treatment guidance prospectively.

A Nomogram Improves AJCC Stages for Colorectal Cancers by Introducing CEA, Modified Lymph Node Ratio and Negative Lymph Node Count

A Nomogram to Predict Adequate Lymph Node Recovery Before Resection of Colorectal Cancer

A neotype nomogram based on accessible clinical indicators to predict the overall survival of esophageal cancer patients underwent radical resection

Construction and Validation of a Simple-to-use Nomogram Incorporating Clinicopathological Parameters into the TNM Staging System to Predict Prognosis for Stage II Colorectal Cancer

Development and Validation of a Nomogram Incorporating Axillary Lymph Node Ratio to Predict Survival in Node-Positive Breast Cancer Patients after Neoadjuvant Chemotherapy

Prognostic Performance Of Lymph Node Staging Systems In Patients With Resectable Gastric Cancer: Comparison Of Population-Based Nomograms.

Comparison of Prognostic Nomograms Based on Different Nodal Staging Systems in Patients with Resected Gastric Cancer.

Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Colorectal Cancer Patients: A Large Population-Based Real-World Study.

A nomogram for individually predicting the overall survival in colonic adenocarcinoma patients presenting with perineural invasion: a population study based on SEER database

Novel Nomograms to Predict Lymph Node Metastasis and Liver Metastasis in Patients with Early Colon Carcinoma

Accurate nomograms with excellent clinical value for locally advanced rectal cancer

AB115. P089. Comparison of Prognostic Prediction Between Nomogram Based on Lymph Node Ratio and AJCC 8th Staging System for Patients with Resected Pancreatic Head Carcinoma: a SEER Analysis

Survival Nomograms for Stage III Colorectal Cancer.

A Predictive Nomogram Improved Diagnostic Accuracy and Interobserver Agreement of Perirectal Lymph Nodes Metastases in Rectal Cancer

Nomogram For Predicting Overall Survival In Stage Ii-Iii Colorectal Cancer

Establishment and Validation of Nomograms for Predicting Mesorectal Lymph Node Staging and Restaging

Application of A Nomogram in Detection of Lymph Node Metastases in T1 Colorectal Cancer

Establishment and Validation of a Prognostic Nomogram for Predicting Postoperative Overall Survival in Advanced Stage III–IV Colorectal Cancer Patients

Nomograms Predicting Survival and Patterns of Failure in Patients with Cervical Cancer Treated with Concurrent Chemoradiotherapy: A Special Focus on Lymph Nodes Metastases

A Nomogram Based on Clinical Factors to Predict Locally Advanced Stage of Rectal Cancer

Development and validation of nomograms based on pre-/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resection